(BIIB:Consolidated Issue Listed on NASDAQ Global Select )
Douglas Edward Williams Ph.D.
|Age||Total Calculated Compensation||This person is connected to 59 board members in 5 different organizations across 15 different industries.|
See Board Relationships
As of Fiscal Year 2013
Dr. Douglas Edward Williams, also known as Doug, Ph.D. served as an Executive Vice President of Research & Development at Biogen Inc. since January 5, 2011 until July 10, 2015. Dr. Williams served as the Chief Executive Officer of Zymogenetics Inc. from January 2, 2009 to November 2010. Dr. Williams served as the President of Zymogenetics Inc. from July 2, 2007 to January 2009. Dr. Williams joined ZymoGenetics Inc. on September 7, 2004 as Chief Scientific Officer and ...
225 Binney StreetPhone: 617-679-2000
Cambridge, Massachusetts 02142
Board Members Memberships*
Director and Member of Governance & Nominating Committee
State University of New York at Buffalo Roswell Park Memorial Institute Division
University of Massachusetts Lowell
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Ali Mortazavi||Chief Executive (leave of absence) and Director|
Silence Therapeutics plc
|Peter French B.Sc, M.Sc, Ph.D., MBA||Chief Executive Officer, Managing Director and Director|
Benitec Biopharma Limited
|Mark W. Schwartz Ph.D.||Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee|
Galena Biopharma, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Arbutus Biopharma Corporation
|Douglas M. Fambrough III, Ph.D.||Co-Founder, Chief Executive Officer, President and Director|
Dicerna Pharmaceuticals, Inc.
|$430.0K||Compensation as of Fiscal Year 2014.|